RLAY vs RVMD Stock Comparison
RLAY currently leads RVMD in this stock comparison, with AIQ scores of 56 vs 55. The clearest difference is quality, while RVMD has the stronger risk resilience profile.
What is the main difference between RLAY and RVMD?
RLAY leads the current stock comparison as Relay Therapeutics, Inc., with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Relay Therapeutics, Inc. vs Revolution Medicines, Inc.
RLAY leads
RLAY leads by 1 AIQ points, primarily on Quality, having only recently taken the lead back from RVMD.
Fragile: 2 of 6 evidence groups support RLAY, the lead recently changed hands, and its current signal state is conflicted.
Relay Therapeutics, Inc.
Revolution Medicines, Inc.
The Algovestiq AIQ Score currently favors RLAY over RVMD, 56 versus 55 as of Nov 15, 2026. RLAY's advantage is driven primarily by stronger quality, while RVMD holds the stronger risk resilience profile. RLAY also shows the stronger technical structure relative to its 50-day moving average. 2 of 6 covered evidence groups favor RLAY today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. RLAY lead: Reversed — RVMD led by 15 AIQ points 30 sessions ago; RLAY now leads by 1.
Compare Relay Therapeutics, Inc. and Revolution Medicines, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare RLAY and RVMD against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience52 vs 59RVMD +7
- Quality47 vs 43RLAY +4
- Momentum76 vs 73Even
- Value37 vs 39Even
2 of 6 evidence groups favor RLAY. RLAY’s edge is concentrated in quality; RVMD keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +2
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.58x)
Largest factor move: Momentum +2
New signals
- BB Lower Band Breach — bullish, volatility, short horizon
- Stochastic Oversold Bounce — bullish, momentum, short horizon
RLAY's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — RLAY and RVMD both carry a full feed there.
The central trade-off
RLAY (Relay Therapeutics, Inc.): the stronger current systematic profile, led by quality.
RVMD (Revolution Medicines, Inc.): the counter-case, on risk resilience, fundamentals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
RLAYRLAY on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
RVMDRVMD on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
EvenThe two are level on Momentum.
Lower downside
RVMDRVMD on Risk Resilience, by 7 points.
Analyst upside
RLAYRLAY on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | RLAY | RVMD | Note |
|---|---|---|---|
| Implied upside to target | +60.3% | +52.3% | RLAY has more room |
| Target dispersion | 0% | +53.7% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 13 | 25 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
2 of 6 covered evidence groups favor RLAY. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 56 vs 55 |
| Fundamentals | RVMDon balance | EPS growth 9.8% vs 37.9%; TTM ROE -10% vs -17%; gross margin 89.3% vs 95.2%; operating margin -30.9% vs -8.5% — RVMD takes 3 of 4 decided legs, not all of them |
| Valuation | Even | Value 37 vs 39 |
| Technicals | RLAY | Price vs 50-day -1.5% vs -11.4%; vs 200-day 16.4% vs 7.8% |
| Risk Resilience | RVMD | Risk Resilience 52 vs 59 |
| Analyst expectations | RLAY | Target upside 60.3% vs 52.3% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of RLAY and RVMD and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
- Only 2 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on RLAY.
How the comparison changed
120 daily snapshots · May 27 – Nov 13RLAY lead: Reversed — RVMD led by 15 AIQ points 30 sessions ago; RLAY now leads by 1.
- Today
- RLAY +1
- 56 vs 55
- 7 sessions ago
- RVMD +2
- 55 vs 57
- 30 sessions ago
- RVMD +15
- 49 vs 64
- 90 sessions ago
- RVMD +9
- 60 vs 69
The lead changed hands once in this window, most recently on Nov 12 when RLAY moved ahead of RVMD.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
3 bullish / 2 bearish / 2 neutral, conflicted
Only RLAY
- ADX Trend Weakening — neutral, trend, medium horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Low Volume Rally Warning — bearish, volume, short horizon (0.58x)
- TRIX Bullish Signal — bullish, momentum, short horizon
3 bullish / 3 bearish / 1 neutral, conflicted
Only RVMD
- BB Lower Band Breach — bullish, volatility, short horizon
- Distribution Pattern — bearish, volume, medium horizon (1.12x)
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
- Stochastic Oversold Bounce — bullish, momentum, short horizon
Both carry 3 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, Beta Spike Warning.
RLAY leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.06%, AIQ +1 points).
Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -2.3%, AIQ +1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1RVMD closes the Quality gap — currently 4 points behind, the largest single contributor to RLAY's edge.
- 2RVMD's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
- 3RLAY's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
RVMD leads on balance| Metric | RLAY | RVMD |
|---|---|---|
| Revenue growth (YoY) | -100% | 0% |
| EPS growth (YoY) | 9.8% | 37.9% |
| Gross margin | 89.3% | 95.2% |
| Operating margin | -30.9% | -8.5% |
| Return on equity (TTM) | -10% | -17% |
| Debt to equity | 0.03 | 0.27 |
Performance
RLAY leads 5 of 6 windows| Metric | RLAY | RVMD |
|---|---|---|
| 1 week (5 sessions) | -2.7% | -10.4% |
| 1 month (20 sessions) | 11.1% | -3.2% |
| 3 months (63 sessions) | -12.5% | -18.7% |
| 6 months (126 sessions) | 48.3% | 18.3% |
| Year to date | 113.8% | 116.3% |
| 1 year (252 sessions) | 193.2% | 161.7% |
Technicals
RLAY has the stronger structure| Metric | RLAY | RVMD |
|---|---|---|
| RSI (14) | 47.9 | 39.7 |
| ADX (14) | 14.3 | 17.6 |
| Price vs 50-day | -1.5% | -11.4% |
| Price vs 200-day | 16.4% | 7.8% |
| Volatility (1M, annualized) | 80.3% | 71% |
Risk
RVMD is the more resilient| Metric | RLAY | RVMD |
|---|---|---|
| Beta | 1.66 | 1.3 |
| Sharpe ratio | 1.84 | 1.69 |
| Sortino ratio | 3.13 | 3.54 |
| Max drawdown | -28.2% | -25% |
| Current drawdown | -12.8% | -22.1% |
| Annualized volatility | 65.8% | 68.7% |
| Value at risk (95%) | -5.4% | -4% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, RLAY or RVMD?
On the Algovestiq AIQ Score, RLAY is the stronger of the two as of Nov 15, 2026, scoring 56 against RVMD's 55. The edge comes from quality. RVMD is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is RLAY or RVMD the better buy right now?
RLAY carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.
Why does the AIQ Score favor RLAY over RVMD?
The composite weights Quality, Value, Momentum and Risk Resilience. RVMD leads Risk Resilience by 7 points; RLAY leads Quality by 4 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, RLAY or RVMD?
Analyst price targets imply +60.3% upside for RLAY and +52.3% for RVMD, so the Street currently favors RLAY. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, RLAY or RVMD?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, RLAY or RVMD?
RVMD on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, RLAY or RVMD?
The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, RLAY or RVMD?
RVMD is the more resilient of the two, so the other name carries the higher downside risk. RVMD on Risk Resilience, by 7 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is RLAY more profitable than RVMD?
The profitability evidence is mixed: gross margin 89.3% vs 95.2%; operating margin -30.9% vs -8.5%; ttm roe -10% vs -17%. RLAY leads on one measure and RVMD on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is RLAY's lead over RVMD getting stronger or weaker?
RLAY lead: Reversed — RVMD led by 15 AIQ points 30 sessions ago; RLAY now leads by 1. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-11-12, when RLAY moved ahead of RVMD.
What would change the RLAY vs RVMD verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: RVMD closes the Quality gap — currently 4 points behind, the largest single contributor to RLAY's edge; RVMD's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; RLAY's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about RLAY and RVMD?
RLAY: 3 bullish / 2 bearish / 2 neutral, conflicted. RVMD: 3 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on RLAY is Golden Cross Active (bullish, long horizon). On RVMD it is Golden Cross Active (bullish, long horizon).
Compare RLAY and RVMD with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.